Overview
Itron, Inc. specializes in providing advanced technology solutions for energy and water resource management. The company offers innovative metering, data collection, and analysis systems to help utilities and cities optimize resource usage and enhance operational efficiency.
AI+ Ask Fintel’s AI assistant about Itron, Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Itron, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 45.71 MM |
| Earnings Date | |
| EPS (TTM) | 5.90 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.08 |
| ROE | 0.21 |
| ROIC | 0.09 |
| CROIC | 0.10 |
| OCROIC | 0.11 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 38.67 /100 |
| Profitability | 76.98 /100 |
| Quality Score | 53.32 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | 84.54 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 6.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Itron, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-08-21 | Roth MKM | Buy | Buy | Maintains |
| 2024-09-27 | Janney Montgomery Scott | Buy | Initiate | |
| 2024-08-05 | Stephens & Co. | Equal-Weight | Equal-Weight | Reiterate |
| 2024-07-17 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-07-16 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-07-16 | Roth MKM | Buy | Buy | Maintains |
| 2024-07-11 | Guggenheim | Neutral | Buy | Upgrade |
| 2024-06-20 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-05-21 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2024-05-06 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-03 | TD Cowen | Buy | Buy | Maintains |
| 2024-05-03 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-05-03 | Roth MKM | Buy | Buy | Maintains |
| 2024-05-03 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-05-03 | Piper Sandler | Overweight | Overweight | Reiterate |
| 2024-04-23 | Roth MKM | Buy | Buy | Maintains |
| 2024-04-11 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-03-13 | TD Cowen | Outperform | Outperform | Maintains |
| 2024-03-13 | Baird | Outperform | Outperform | Maintains |
| 2024-03-13 | JP Morgan | Neutral | Neutral | Maintains |
| 2024-02-27 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-02-27 | Baird | Neutral | Outperform | Upgrade |
| 2024-01-19 | Oppenheimer | Perform | Outperform | Upgrade |
| 2024-01-04 | Raymond James | Outperform | Market Perform | Downgrade |
| 2023-12-19 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2023-12-12 | JP Morgan | Underweight | Neutral | Upgrade |
| 2023-12-05 | Roth MKM | Buy | Initiate | |
| 2023-12-01 | Canaccord Genuity | Hold | Initiate | |
| 2023-11-03 | Piper Sandler | Neutral | Neutral | Maintains |
| 2023-10-19 | JP Morgan | Underweight | Underweight | Maintains |
| 2023-10-06 | Piper Sandler | Neutral | Neutral | Maintains |
| 2023-09-22 | Seaport Global | Buy | Initiate | |
| 2023-09-11 | Guggenheim | Neutral | Initiate | |
| 2023-08-18 | Argus Research | Hold | Buy | Upgrade |
| 2023-08-04 | TD Cowen | Outperform | Outperform | Maintains |
| 2023-08-04 | Baird | Neutral | Neutral | Maintains |
| 2023-07-12 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2023-05-08 | Piper Sandler | Neutral | Maintains | |
| 2023-05-05 | EF Hutton | Buy | Maintains | |
| 2023-05-05 | Baird | Neutral | Maintains | |
| 2023-05-05 | Raymond James | Strong Buy | Maintains | |
| 2023-03-03 | JP Morgan | Neutral | Underweight | Downgrade |
| 2023-02-28 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2023-02-28 | Piper Sandler | Neutral | Maintains | |
| 2023-02-28 | EF Hutton | Buy | Reiterate | |
| 2023-02-28 | Baird | Neutral | Maintains | |
| 2023-02-28 | Raymond James | Strong Buy | Maintains | |
| 2023-02-02 | Cowen & Co. | Outperform | Maintains | |
| 2022-11-04 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-11-04 | EF Hutton | Buy | Maintains | |
| 2022-11-04 | Raymond James | Strong Buy | Maintains | |
| 2022-10-20 | JP Morgan | Neutral | Maintains | |
| 2022-08-08 | JP Morgan | Overweight | Neutral | Downgrade |
| 2022-08-05 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2022-07-20 | JP Morgan | Overweight | Maintains | |
| 2022-07-19 | Piper Sandler | Neutral | Maintains | |
| 2022-07-12 | Raymond James | Strong Buy | Maintains | |
| 2022-06-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-03 | EF Hutton | Buy | Maintains | |
| 2022-03-02 | Stephens & Co. | Overweight | Maintains | |
| 2022-03-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-03-01 | EF Hutton | Buy | Maintains | |
| 2022-03-01 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-01-10 | Wells Fargo | Equal-Weight | Maintains | |
| 2021-12-20 | Argus Research | Buy | Hold | Downgrade |
| 2021-11-08 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-10-06 | Oppenheimer | Outperform | Perform | Downgrade |
| 2021-09-30 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-08-06 | Baird | Outperform | Neutral | Downgrade |
| 2021-08-06 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2021-07-21 | JP Morgan | Overweight | Maintains | |
| 2021-06-18 | Piper Sandler | Overweight | Maintains | |
| 2021-05-04 | Oppenheimer | Outperform | Maintains | |
| 2021-03-31 | Morgan Stanley | Equal-Weight | Initiate | |
| 2021-03-26 | JP Morgan | Overweight | Initiate | |
| 2021-03-26 | Piper Sandler | Overweight | Initiate | |
| 2021-03-03 | Argus Research | Hold | Buy | Upgrade |
| 2021-02-25 | Oppenheimer | Outperform | Maintains | |
| 2021-01-08 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2020-09-28 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2020-08-04 | Raymond James | Outperform | Maintains | |
| 2020-05-05 | JMP Securities | Market Outperform | Maintains | |
| 2020-03-19 | Argus Research | Buy | Hold | Downgrade |
| 2020-02-26 | Stephens & Co. | Equal-Weight | Reiterate | |
| 2019-11-05 | Baird | Outperform | Maintains | |
| 2019-10-21 | Canaccord Genuity | Buy | Maintains | |
| 2019-10-01 | Raymond James | Outperform | Maintains | |
| 2019-09-18 | Baird | Outperform | Maintains | |
| 2019-08-20 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2019-08-16 | Argus | Hold | Buy | Upgrade |
| 2019-07-09 | Stephens & Co. | Equal-Weight | Initiate | |
| 2019-05-07 | Baird | Neutral | Outperform | Upgrade |
| 2019-02-28 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-11-08 | Argus | Buy | Hold | Downgrade |
| 2018-08-07 | Baird | Neutral | Neutral | Maintains |
| 2018-08-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2018-03-01 | JMP Securities | Market Outperform | Market Outperform | Maintains |
| 2018-03-01 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2018-02-27 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2018-01-02 | Raymond James | Strong Buy | Initiate | |
| 2017-11-29 | Argus | Buy | Hold | Downgrade |
| 2017-09-19 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2017-09-12 | Argus | Buy | Maintains | |
| 2017-07-26 | Baird | Outperform | Neutral | Downgrade |
| 2017-07-18 | JMP Securities | Market Outperform | Maintains | |
| 2017-03-09 | JMP Securities | Market Outperform | Initiate | |
| 2016-11-03 | Oppenheimer | Perform | Outperform | Upgrade |
| 2016-10-03 | Canaccord Genuity | Buy | Maintains | |
| 2016-03-03 | Argus | Hold | Buy | Upgrade |
| 2016-01-12 | Wedbush | Outperform | Initiate | |
| 2015-10-19 | Canaccord Genuity | Hold | Buy | Upgrade |
| 2015-09-11 | Oppenheimer | Perform | Initiate | |
| 2015-07-20 | Canaccord Genuity | Hold | Maintains | |
| 2015-02-12 | Canaccord Genuity | Hold | Maintains | |
| 2014-09-10 | Canaccord Genuity | Hold | Maintains | |
| 2014-08-12 | Northland Securities | Market Perform | Initiate | |
| 2014-08-06 | Macquarie | Neutral | Maintains | |
| 2014-08-06 | Canaccord Genuity | Hold | Maintains | |
| 2014-08-06 | JP Morgan | Underweight | Maintains | |
| 2014-08-06 | Brean Capital | Sell | Hold | Upgrade |
| 2014-07-21 | Bank of America | Buy | Underperform | Downgrade |
| 2014-05-28 | Stifel Nicolaus | Hold | Initiate | |
| 2014-05-05 | Credit Suisse | Neutral | Maintains | |
| 2014-04-28 | Baird | Outperform | Maintains | |
| 2014-03-05 | Stephens & Co. | Equal-Weight | Initiate | |
| 2014-02-14 | Stifel | Sell | Hold | Upgrade |
| 2014-02-13 | Canaccord Genuity | Buy | Hold | Downgrade |
| 2014-02-13 | JP Morgan | Neutral | Underweight | Downgrade |
| 2014-02-13 | Brean Capital | Hold | Sell | Downgrade |
| 2014-02-13 | Credit Suisse | Neutral | Maintains | |
| 2014-02-12 | Needham | Hold | Buy | Upgrade |
| 2014-01-08 | Argus | Buy | Hold | Downgrade |
| 2013-10-31 | Janney Capital | Buy | Neutral | Downgrade |
| 2013-08-01 | Brean Capital | Hold | Sell | Downgrade |
| 2013-04-29 | UBS | Neutral | Maintains | |
| 2013-03-05 | UBS | Neutral | Maintains | |
| 2013-02-15 | Bank of America | Buy | Maintains | |
| 2013-02-14 | Brean Capital | Buy | Hold | Downgrade |
| 2013-02-14 | Jefferies | Hold | Maintains | |
| 2013-02-14 | Wedbush | Outperform | Maintains | |
| 2013-02-14 | JP Morgan | Overweight | Neutral | Downgrade |
| 2013-01-16 | Jefferies | Buy | Hold | Downgrade |
| 2012-11-29 | JP Morgan | Overweight | Maintains | |
| 2012-11-02 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-11-02 | Canaccord Genuity | Buy | Maintains | |
| 2012-10-15 | Stifel Nicolaus | Hold | Sell | Downgrade |
| 2012-08-31 | Cantor Fitzgerald | Hold | Maintains | |
| 2012-08-03 | UBS | Neutral | Maintains | |
| 2012-07-05 | Canaccord Genuity | Buy | Maintains | |
| 2012-04-26 | Jefferies | Buy | Maintains | |
| 2012-04-26 | Morgan Stanley | Overweight | Maintains | |
| 2012-02-27 | UBS | Neutral | Maintains | |
| 2012-02-16 | Wunderlich | Sell | Maintains | |
| 2012-02-16 | Brean Capital | Buy | Maintains | |
| 2012-02-16 | Morgan Stanley | Overweight | Maintains | |
| 2024-11-06 | Guggenheim | Buy | Buy | Maintains |
| 2025-02-27 | Guggenheim | Buy | Buy | Maintains |
| 2025-02-27 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-02-26 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-02-26 | Canaccord Genuity | Buy | Buy | Maintains |
| 2024-11-01 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-11-01 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-11-01 | Roth MKM | Buy | Buy | Maintains |
| 2024-11-01 | TD Cowen | Buy | Buy | Maintains |
| 2024-11-01 | Baird | Outperform | Outperform | Maintains |
| 2024-08-02 | Baird | Outperform | Outperform | Maintains |
| 2024-08-02 | Roth MKM | Buy | Buy | Maintains |
| 2024-07-22 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-04-17 | Guggenheim | Buy | Buy | Reiterate |
| 2025-07-31 | JP Morgan | Neutral | Overweight | Upgrade |
| 2025-07-14 | Guggenheim | Buy | Buy | Maintains |
| 2025-05-05 | Piper Sandler | Neutral | Neutral | Maintains |
| 2025-07-22 | Roth Capital | Buy | Buy | Maintains |
| 2025-07-22 | JP Morgan | Neutral | Neutral | Maintains |
